NHS
Image generated by AI
UK researchers warn NHS rollout of Mounjaro could widen inequalities in obesity care
Reported by AI Image generated by AI Fact checked
UK specialists say strict early access rules for the weight-loss drug tirzepatide (Mounjaro) risk creating a “two-tier” obesity treatment system, with people who can pay privately getting faster access than those relying on the National Health Service.
A Cl0p ransomware attack has affected patient and staff data at Barts Health NHS. The breach occurred through the organization's Oracle E-Business Suite. Details emerged in a recent report on the incident.